Semaglutide drug may reverse chronic kidney disease damage
Researchers report that the weight loss drug semaglutide helps repair blood vessels and reduce inflammation in damaged human kidneys.
The study published in Nature Medicine shows the medication restores vital filters inside the waste disposal systems of patients worldwide. This work confirms the drug can help fix faulty organs effectively during clinical testing.
Chronic kidney disease impacts an estimated 674 million people globally. Diabetes and high blood pressure are the most common causes of the condition. As the illness progresses, the organs slowly lose their ability to filter waste and remove it from circulation.
People with diabetic kidney issues who took the medication faced lower risks of kidney failure. They also had reduced chances of dying from a heart attack compared to those taking a placebo. A previous trial was stopped early because the medication proved so successful at saving lives that continuing the placebo was deemed unethical.
The new study examined kidney tissue samples before and after participants took the medication to find out exactly how the drug worked inside the body. Researchers found striking visible changes including better blood flow, less scarring, and softer blood vessels which serves as a key measure of vessel health.

